Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Name: Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan
Published: 2018
License: Public Domain

Keio University · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

autoimmune-disease rheumatoid-arthritis

rheumatoid arthritis, methotrexate, adalimumab, autoimmune disease, connective tissue diseases, rheumatic disease, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Related documents